Chronic stress destabilizes the biological and behavioral systems that support long-term recovery, increasing the likelihood of substance use relapse. Research describing how prolonged stress alters brain circuits and stress hormones helps explain why people in recovery often return to substance use after traumatic or sustained stressful experiences. Bruce McEwen at Rockefeller University framed this process as allostatic load, the cumulative wear on the brain and body from chronic stress that shifts baseline functioning toward vulnerability. Rajita Sinha at Yale University links these shifts to heightened craving and impaired coping in human studies, while Nora Volkow at the National Institute on Drug Abuse documents stress-related changes in the brain’s reward and control networks that influence relapse risk.
Neurobiology and behavioral mechanisms
Chronic activation of the hypothalamic-pituitary-adrenal axis and stress peptides such as corticotropin-releasing factor produce persistent elevations or dysregulation of stress hormones, which in turn alter the extended amygdala and mesolimbic dopamine systems implicated in motivation and reward. George Koob at Scripps Research describes how these neuroadaptations generate a negative emotional state that drives compulsive drug-seeking as a form of negative reinforcement. At the same time, stress impairs prefrontal cortex functions responsible for decision-making and impulse control, reducing capacity to resist cues or cravings. Rajita Sinha’s neuroimaging and laboratory stress-provocation work at Yale University shows that stress-induced craving corresponds with reduced frontal control and greater limbic reactivity in people with substance use disorders.
Context, causes, and consequences
Chronic stress often arises from social and environmental sources such as poverty, discrimination, unstable housing, and unresolved trauma, and these factors vary across communities and cultures. Context-dependent stressors can make relapse risk particularly high in territories or populations with concentrated adversity and limited access to treatment. The consequences extend beyond individual relapse to higher rates of overdose, medical complications, and social harm when stressors persist without intervention. Clinical research informed by Rajita Sinha at Yale University and programmatic guidance from Nora Volkow at the National Institute on Drug Abuse support integrating stress regulation into relapse prevention through trauma-informed care, behavioral therapies that rebuild executive control, and public health measures addressing social determinants. Understanding chronic stress as a mechanistic driver of relapse reframes recovery strategies toward reducing allostatic load and strengthening resilience in both individuals and communities.